Recent Quotes (30 days)

You have no recent quotes
chg | %

Finance

Results 1 - 11 of about 11 for Bell Laboratories, Inc
Company Exchange Symbol Last price Quote change Market cap
Berkshire Hathaway Inc. NYSE BRK.A 215,865.00 -4,133.00 (-1.88%) 354.63B
Berkshire Hathaway Inc. (Berkshire) is a holding company owning subsidiaries engaged in a number of diverse business activities. The Company is engaged in ...
Berkshire Hathaway Inc. NYSE BRK.B 143.91 -2.38 (-1.63%) 354.63B
Berkshire Hathaway Inc. (Berkshire) is a holding company owning subsidiaries engaged in a number of diverse business activities. The Company is engaged in ...
BERKSHIRE HATHAWAY A DL 5 ETR BRH 191,350.00 0.00 (0.00%)
BERKSHIRE HATHAWAY A DL 5 FRA BRH 192,200.00 +1,950.00 (1.02%)
BERKSH. H.B NEW DL-,00333 FRA BRYN 128.75 -0.25 (-0.20%)
BERKSHIRE -DRN BVMF BERK34 382.06 0.00 (0.00%)
Roche Holding Ltd. VTX ROG 248.60 -4.10 (-1.62%) 214.68B
Roche Holding AG is a Switzerland-based pharmaceuticals and diagnostics company. It discovers, develops and provides diagnostic and therapeutic products and ...
Executive:
John Irving Bell
Roche Holding Ltd. (ADR) OTCMKTS RHHBY 33.76 -0.62 (-1.79%) 236.84B
Roche Holding AG is a Switzerland-based pharmaceuticals and diagnostics company. It discovers, develops and provides diagnostic and therapeutic products and ...
Executive:
John Irving Bell
Roche Holding AG FRA RHO5
Roche Holding AG is a Switzerland-based pharmaceuticals and diagnostics company. It discovers, develops and provides diagnostic and therapeutic products and ...
Executive:
John Irving Bell
Roche Holding Ltd. (Bearer Share) SWX RO 252.75 -1.50 (-0.59%)
Roche Holding AG is a Switzerland-based pharmaceuticals and diagnostics company. It discovers, develops and provides diagnostic and therapeutic products and ...
Executive:
John Irving Bell
Roche Holding AG ETR RHO5 107.35 +1.50 (1.42%) 0.00
Roche Holding AG is a Switzerland-based pharmaceuticals and diagnostics company. It discovers, develops and provides diagnostic and therapeutic products and ...
Executive:
John Irving Bell